The Effect of Potentiostatic Control on the Bioreduction of Hexavalent Chromium Using Bacillus cereus
Abstract
Coupling microbial catalysis with electrochemical stimulation offers a promising strategy for heavy metal remediation. This study investigates how potentiostatic control influences the bioreduction of hexavalent chromium (Cr(VI)) by Bacillus cereus strain DIF1 in a bioelectrochemical system. Cr(VI) reduction was evaluated under various applied cathodic potentials, and the highest reduction efficiency (91.45%) was achieved at +0.04 V after 24 h. This performance significantly surpassed that of the abiotic control (82.55%) and the open-circuit biotic control (9.25%), indicating that the applied potential enhances microbial Cr(VI) reduction beyond contributions from abiotic processes alone. Cyclic voltammetry (CV) revealed a distinct redox feature at +0.04 V with no corresponding reverse peak, indicating kinetically favored electron transfer during Cr(VI) reduction under this condition. Microscopic imaging confirmed that, under the applied potential, Bacillus cereus DIF1 formed filamentous connections, exhibited higher chromium accumulation on bacterial cells than on the surrounding carbon paper electrode, and developed a robust biofilm on the cathode surface. The system maintained consistent Cr(VI) reduction performance over three consecutive cycles, demonstrating good short-term operational reproducibility. These findings highlight the critical role of precise electrochemical control in modulating microbial Cr(VI) reduction and provide mechanistic insights into the interplay…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.